Correlation Between Dyadic International and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and DiaMedica Therapeutics, you can compare the effects of market volatilities on Dyadic International and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and DiaMedica Therapeutics.
Diversification Opportunities for Dyadic International and DiaMedica Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyadic and DiaMedica is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and DiaMedica Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 0.99 times more return on investment than DiaMedica Therapeutics. However, Dyadic International is 1.01 times less risky than DiaMedica Therapeutics. It trades about -0.09 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 164.00 in Dyadic International on January 25, 2024 and sell it today you would lose (15.00) from holding Dyadic International or give up 9.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. DiaMedica Therapeutics
Performance |
Timeline |
Dyadic International |
DiaMedica Therapeutics |
Dyadic International and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and DiaMedica Therapeutics
The main advantage of trading using opposite Dyadic International and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 TherapeuticsInc |
DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase TherapeuticsInc | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |